PERNIX THERAPEUTICS HLDGS IN's ticker is and the CUSIP is 71426VAK4. A total of 12 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $221,000 | -76.0% | 2,000,000 | 0.0% | 0.02% | -72.7% |
| Q3 2018 | $922,000 | +2.3% | 2,000,000 | 0.0% | 0.06% | +1.9% |
| Q2 2018 | $901,000 | -2.3% | 2,000,000 | 0.0% | 0.05% | -6.9% |
| Q1 2018 | $922,000 | +0.1% | 2,000,000 | 0.0% | 0.06% | -17.1% |
| Q4 2017 | $921,000 | +6.8% | 2,000,000 | 0.0% | 0.07% | +4.5% |
| Q3 2017 | $862,000 | +38.8% | 2,000,000 | 0.0% | 0.07% | +17.5% |
| Q2 2017 | $621,000 | +6.7% | 2,000,000 | 0.0% | 0.06% | -3.4% |
| Q1 2017 | $582,000 | +6.6% | 2,000,000 | 0.0% | 0.06% | +13.5% |
| Q4 2016 | $546,000 | -26.4% | 2,000,000 | 0.0% | 0.05% | -50.0% |
| Q3 2016 | $742,000 | +39.7% | 2,000,000 | 0.0% | 0.10% | -19.4% |
| Q2 2016 | $531,000 | – | 2,000,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZAZOVE ASSOCIATES LLC | 2,000,000 | $36,000 | 0.00% |
| Bruce & Co., Inc. | 2,000,000 | $10,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |